- Home
- INBX vs CVRX Comparison
INBX vs CVRX Comparison
Compare INBX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- CVRX
- Stock Information
- Founded
- INBX 2010
- CVRX 2000
- Country
- INBX United States
- CVRX United States
- Employees
- INBX N/A
- CVRX N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INBX Health Care
- CVRX Health Care
- Exchange
- INBX Nasdaq
- CVRX Nasdaq
- Market Cap
- INBX 178.5M
- CVRX 202.8M
- IPO Year
- INBX 2020
- CVRX 2021
- Fundamental
- Price
- INBX $11.28
- CVRX $5.44
- Analyst Decision
- INBX Hold
- CVRX Buy
- Analyst Count
- INBX 1
- CVRX 7
- Target Price
- INBX N/A
- CVRX $14.50
- AVG Volume (30 Days)
- INBX 94.2K
- CVRX 444.5K
- Earning Date
- INBX 05-20-2025
- CVRX 05-08-2025
- Dividend Yield
- INBX 7.45%
- CVRX N/A
- EPS Growth
- INBX N/A
- CVRX N/A
- EPS
- INBX 112.62
- CVRX N/A
- Revenue
- INBX $200,000.00
- CVRX $52,870,000.00
- Revenue This Year
- INBX N/A
- CVRX $22.17
- Revenue Next Year
- INBX N/A
- CVRX $24.02
- P/E Ratio
- INBX $0.10
- CVRX N/A
- Revenue Growth
- INBX N/A
- CVRX 25.62
- 52 Week Low
- INBX $10.80
- CVRX $5.81
- 52 Week High
- INBX $18.95
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- INBX 41.19
- CVRX 34.75
- Support Level
- INBX $10.90
- CVRX $4.30
- Resistance Level
- INBX $11.98
- CVRX $7.91
- Average True Range (ATR)
- INBX 0.85
- CVRX 0.61
- MACD
- INBX -0.02
- CVRX -0.03
- Stochastic Oscillator
- INBX 19.75
- CVRX 28.66
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.